Imagine trying to watch people move through a crowded party, but every time someone steps into the most interesting conversations, they vanish into the wall behind them. That's been the problem for scientists studying what happens inside living cells — until now.
Researchers at the University of Illinois Chicago have created a new imaging technique called FINICI, short for Fluctuation Increase Negated by Intra-Chain. The method lets scientists see enzyme activity in tiny regions of a cell that was completely invisible before. Their findings were published in the journal Proceedings of the National Academy of Sciences.
Cells are incredibly busy places. Thousands of molecules interact in tight spaces, constantly passing signals back and forth. Scientists use tools called biosensors — fluorescent molecules that light up or dim when they detect activity — to watch these interactions happen. But there's a catch: when biosensors go dark instead of lighting up, the most important parts of the action can blend into the background, like wearing a green shirt in front of a green screen.
"Because these biosensors go dark, some parts of the foreground, where the action is, blend into the background," said Gary Mo, a co-author of the study and associate professor at UIC. This meant scientists were missing crucial information about where signals actually originate and spread.
FINICI flips that problem on its head. The technique converts those dark signals into bright, readable ones, without requiring scientists to redesign existing biosensors — a process that could take years. Using FINICI, the team watched three molecules at work: Src kinase (a protein involved in cancer and cell movement), Syk kinase (found in immune cells), and cGMP (a signaling molecule).
What they discovered challenges old assumptions. In immune cells, the enzyme Syk was most active near the cell's internal scaffolding, not near the receptors that are supposed to activate it. The signaling molecule cGMP formed small clusters that disappeared quickly as signals spread. And Src kinase showed bursts of activity in tiny cholesterol-rich areas of the cell membrane called lipid rafts.
The real estate comparison is fitting, said Mo: "You have to be in the room to do the job. If an enzyme isn't in the right place, it doesn't matter if it's active — it can do the work, but it's not going to."
That insight could change how drugs are developed. Many medications are designed to target enzymes and signaling pathways, but their effectiveness may depend on whether they reach the right location within a cell. By showing exactly where signals happen in real time, FINICI gives researchers a clearer picture of how drugs work — and why they sometimes fail.
"Cell signaling determines how drugs work," Mo said. "Visualizing these details is a significant step that helps to understand and improve how they work."